Cargando…
(700) Vaccination with >2 Doses of Mrna Vaccines is Needed to Reduce Mortality Among Lung Transplant Recipients with Covid-19
PURPOSE: Vaccination reduces COVID-19-related morbidity and mortality in the general population, however, the response to vaccination is attenuated among immunosuppressed lung transplant recipients (LTR). Boyarski et al noted that 61% of LTR had no serologic response to the first or second dose of m...
Autores principales: | Sindu, D., Razia, D., Grief, K., Schaheen, L., Padiyar, J., Smith, M.A., Bremner, R.M., Omar, A., Walia, R., Tokman, S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068093/ http://dx.doi.org/10.1016/j.healun.2023.02.714 |
Ejemplares similares
-
(698) Covid-19 is Less Severe with the Omicron Variant Compared to Prior Variants and the Original Sars-Cov-2 Strain in Lung Transplant Recipients
por: Sindu, D., et al.
Publicado: (2023) -
Outcomes of Critically Ill Lung Transplant Recipients with COVID-19
por: Razia, D., et al.
Publicado: (2022) -
(349) Molnupiravir vs Remdesivir for Treatment of Covid-19 in Lung Transplant Recipients
por: Razia, D., et al.
Publicado: (2023) -
Pre-exposure Prophylaxis with Tixagevimab-cilgavimab did not Reduce Severity of COVID-19 in Lung Transplant Recipients with Breakthrough Infection
por: Sindu, Devika, et al.
Publicado: (2023) -
COVID-19 Has a High Mortality Rate in Lung Transplant Recipients: A Large Single-Center Experience
por: Razia, D., et al.
Publicado: (2022)